Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this summary , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this summary . 白云 山 廣州 白雲 山 医药 集团 股份有限公司 GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO . , LTD . ( a joint stock company with limited liability established in the People's Republic of China ) ( H Share Stock Code : 0874 ) SUMMARY OF THE 2021 INTERIM REPORT 1 . IMPORTANT NOTICE 1.1 This summary is extracted from the full text of the 2021 interim report of the Company for the six months ended 30 June 2021. Investors who wish to know more details are advised to read in details the full text of the 2021 interim report which will be published on , among others , the website of SSE ( http://www.sse.com.cn ) or other websites designated by CSRC , and on the website of HKEX ( http://www.hkex.com.hk ) . 1.2 The Board , the Supervisory Committee and the Directors , Supervisors and senior management of the Company collectively and individually accept full responsibility for the truthfulness , accuracy and completeness of the information contained in this summary and confirm that there are no false information , misleading statements or material omissions in this summary . 1.3 The Directors were present at the 15th meeting of the eighth session of the Board , among whom , Mr. Wong Hing Wing , an independent non - executive director , attended the meeting by telephone . 1.4 The financial reports of the Group and the Company for the Reporting Period are prepared in accordance with the China Accounting Standards for Business Enterprises and are unaudited . 1.5 All information required to be contained in the summary of the 2021 interim report of the Company pursuant to paragraph 46 of Appendix 16 to the Listing Rules of HKEX shall be published on the website of HKEX ( http://www.hkex.com.hk ) . 1.6 This summary is prepared in both English and Chinese . In the event of discrepancy in interpretation , the Chinese version shall prevail . -1-